NextPlat (NXPL) Retained Earnings (2010 - 2026)
NextPlat's (NXPL) quarterly Retained Earnings came in at $77.9 million in Q2 2026, up 2.91% year-over-year from $75.7 million in Q2 2025, and little changed quarter-over-quarter from $77.8 million in Q1 2026.
Analysis
NextPlat (NXPL) Retained Earnings (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Retained Earnings for 17 consecutive years, with $77.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings rose 2.91% year-over-year to $77.9 million in Q2 2026; TTM through Jun 2026 was $77.9 million, a 2.91% increase from a year earlier, with the FY2025 full-year figure at $77.6 million, up 2.5% from the prior year.
- Retained Earnings was $77.9 million for Q2 2026 at NextPlat, roughly flat from $77.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at $77.9 million in Q2 2026 and troughed at $46.6 million in Q1 2022.
- A 5-year average of $66.4 million and a median of $68.0 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 204.29% in 2022 and grew 2.5% in 2025, its largest moves.
- Over 5 years, Retained Earnings stood at $57.0 million in 2022, then grew by 17.92% to $67.2 million in 2023, then grew by 12.69% to $75.7 million in 2024, then advanced by 2.5% to $77.6 million in 2025, then increased by 0.42% to $77.9 million in 2026.
- The last three Retained Earnings figures came in at $77.9 million (Q2 2026), $77.8 million (Q1 2026), and $77.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | -10.83 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 620.25 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -2.48 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | -227.25 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 77.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.91 Mn |
| Mar 31, 2026 | 77.85 Mn |
| Dec 31, 2025 | 77.59 Mn |
| Sep 30, 2025 | 75.91 Mn |
| Jun 30, 2025 | 75.71 Mn |
| Mar 31, 2025 | 75.70 Mn |
| Dec 31, 2024 | 75.70 Mn |
| Sep 30, 2024 | 68.49 Mn |
| Jun 30, 2024 | 68.35 Mn |
| Mar 31, 2024 | 67.72 Mn |
| Dec 31, 2023 | 67.17 Mn |
| Sep 30, 2023 | 66.47 Mn |
| Jun 30, 2023 | 65.17 Mn |
| Mar 31, 2023 | 57.02 Mn |
| Dec 31, 2022 | 56.96 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 47.21 Mn |
| Mar 31, 2022 | 46.55 Mn |
| Dec 31, 2021 | 39.51 Mn |
| Sep 30, 2021 | 37.09 Mn |